Agilent Technologies, Inc. $A Shares Sold by Gateway Investment Advisers LLC

Key Points

• Gateway Investment Advisers cut its Agilent Technologies stake by 82.9% in the second quarter, selling 60,057 shares and retaining 12,355 shares valued at approximately $1.64 million. Other institutional investors, including Mitsubishi UFJ Asset Management and Mirae Asset Global Investments, increased their positions.
• Wall Street maintains a generally positive view of Agilent, with analysts assigning an overall “Moderate Buy” rating and an average price target of $160.24. Recent targets range from $135 to $175.
• Agilent shares opened at $148.28, while the company reported quarterly EPS of $1.49 and revenue of $1.83 billion, surpassing estimates. It also declared a quarterly dividend of $0.255 per share, representing a 0.7% annualized yield.

Gateway Investment Advisers LLC decreased its position in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 82.9% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 12,355 shares of the medical research company's stock after selling 60,057 shares during the quarter. Gateway Investment Advisers LLC's holdings in Agilent Technologies were worth $1,641,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also made changes to their positions in A. Mitsubishi UFJ Asset Management Co. Ltd. increased its holdings in shares of Agilent Technologies by 4.3% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 599,581 shares of the medical research company's stock worth $82,712,000 after purchasing an additional 24,687 shares during the period. Mirae Asset Global Investments Co. Ltd. boosted its stake in Agilent Technologies by 20.9% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 53,422 shares of the medical research company's stock valued at $7,269,000 after buying an additional 9,236 shares during the period. Crossmark Global Holdings Inc. grew its position in Agilent Technologies by 39.6% during the fourth quarter. Crossmark Global Holdings Inc. now owns 33,918 shares of the medical research company's stock worth $4,615,000 after buying an additional 9,615 shares in the last quarter. Capricorn Fund Managers Ltd bought a new position in Agilent Technologies in the 1st quarter worth about $8,161,000. Finally, Assetmark Inc. raised its holdings in shares of Agilent Technologies by 5.9% in the 4th quarter. Assetmark Inc. now owns 234,275 shares of the medical research company's stock valued at $31,878,000 after acquiring an additional 12,984 shares in the last quarter.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the company. Jefferies Financial Group assumed coverage on Agilent Technologies in a research report on Thursday, July 9th. They set a "hold" rating and a $135.00 price target for the company. HSBC decreased their price objective on shares of Agilent Technologies from $180.00 to $165.00 and set a "buy" rating on the stock in a research report on Wednesday, June 3rd. Sanford C. Bernstein started coverage on shares of Agilent Technologies in a research report on Friday, June 26th. They set an "outperform" rating and a $155.00 target price for the company. Morgan Stanley lifted their target price on shares of Agilent Technologies from $160.00 to $175.00 and gave the company an "overweight" rating in a research report on Wednesday. Finally, TD Cowen boosted their price target on shares of Agilent Technologies from $147.00 to $155.00 and gave the stock a "buy" rating in a research note on Thursday, May 28th. Two research analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $160.24.

Agilent Technologies Trading Down 0.8%

Shares of A stock opened at $148.28 on Thursday. The business has a 50-day moving average price of $134.90 and a two-hundred day moving average price of $125.30. Agilent Technologies, Inc. has a 12-month low of $108.35 and a 12-month high of $160.27. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43. The firm has a market cap of $41.88 billion, a P/E ratio of 29.78, a price-to-earnings-growth ratio of 2.65 and a beta of 1.25.

Agilent Technologies (NYSE:A - Get Free Report) last announced its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, beating the consensus estimate of $1.41 by $0.08. The firm had revenue of $1.83 billion for the quarter, compared to analyst estimates of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The company's revenue was up 10.0% on a year-over-year basis. During the same period in the prior year, the company earned $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Equities analysts anticipate that Agilent Technologies, Inc. will post 6.03 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th were given a dividend of $0.255 per share. This represents a $1.02 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date was Tuesday, June 30th. Agilent Technologies's dividend payout ratio (DPR) is presently 20.48%.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source